Navigation Links
Interleukin Genetics Grants LABEC Pharma a License for Sales and Distribution of Its Heart Health Genetic Test
Date:4/6/2009

- LABEC Pharma to Introduce Test Product in Spain and Portugal

- Companies plan to seek CE Mark

WALTHAM, Mass. and MADRID, Spain, April 6 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) and LABEC Pharma, S.L. announced today that the companies have entered a licensing agreement to permit LABEC Pharma to market and sell Interleukin Genetics' Heart Health genetic test throughout Spain and Portugal. This molecular diagnostic tool helps to identify individuals at elevated risk for early heart attack. As part of the agreement, the test will be marketed by LABEC Pharma and the tests will be processed at Interleukin Genetics' CLIA-certified laboratory in Waltham, MA. Interleukin Genetics will receive royalties and commercial milestone payments. The Interleukin Genetics' Heart Health test is currently marketed within the United States under the brand name Gensona(R).

"We are excited about this partnership with LABEC Pharma, which will allow for broader and international distribution of this important genetic test product," said Lewis H. Bender, CEO, Interleukin Genetics, Inc. "Our Heart Health genetic test can give a better understanding of a person's overall risk for heart attack, so that individuals and their physicians can begin to take the steps necessary for lowering risk to improve health outcomes."

"Early intervention is a critical step in helping people stay healthy. We are pleased to begin offering the Interleukin Genetics' Heart Health genetic test, which we believe fits well with our existing sales efforts in diagnostic products for disease management and prevention. Being able to offer this test in Spain and Portugal is great news for patients in these two countries," said Javier de Echevarria, CEO, LABEC Pharma.

In recent ye
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Interleukin Genetics Receives NYSE Amex Staff Determination, Requests Oral Hearing Before the Listing Qualifications Panel
2. Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter 2008 Results
3. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
4. Interleukin Genetics Submits Plan to Regain Compliance with Continued Listing Standards
5. Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
6. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
7. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
8. Interleukin Genetics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
9. Interleukin-12 indicates survival prospects for melanoma patients
10. LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
11. Interleukin Genetics Reports Fourth Quarter and Year End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... The Holiday Inn Westbury - Long Island ... Association to donate various items consisting of practical, ... such items.The Association's program is aimed toward helping over ... nursing homes, assisted living facilities and nursing homes. The ... of seniors throughout the Long Island area. The Holiday ...
(Date:11/24/2014)... SafeHandles™ announced that they will be ... Begley Jr, airing via Discovery Channel. Dates and show ... passive, non-invasive, replaceable, and affordable germ protective device. This ... sleeves and adhesives to promote hand hygiene in high ... of SafeHandles is the desire to make a positive ...
(Date:11/24/2014)... "My friend was killed when a vehicle ... street in his motorized wheelchair," said an inventor from ... up with this idea so that people in wheelchairs ... the Safety Lites to make a wheelchair highly visible, ... ensures that motorists can see the wheelchair. This helps ...
(Date:11/23/2014)... The report, “Market Snapshot: Aesthetic ... - Asia-Pacific” provides quantitative analysis of the three ... invasive body contouring devices, non-invasive body contouring devices ... size data by revenue and volume over the ... Japan, South Korea, Australia and India. It uses ...
(Date:11/23/2014)... -- Close friends have more influence on teens, alcohol ... study says. "We,ve known for a long ... individual alcohol use, but there are no common studies ... friend group,s influence on those decisions," Jonathon Beckmeyer, an ... said in a university news release. Beckmeyer analyzed ...
Breaking Medicine News(10 mins):Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Close Friends May Be Key to Teens' Drinking 2
... will be set up in Jharkhand to preserve the rare herbal ... tied up with yoga guru Ramdev in setting up the herbarium.// ... set up the herbarium at Bariatu in Ranchi with an initial ... TRI in the project. ,"We have started work to ...
... Boston - Make no bones about it – For those troubled ... it. According to a study, Amgen Inc.'s experimental drug Denosumab taken ... the spine. // ,The New England Journal of Medicine ... use and observation, which has formed part of the experimental study. ...
... University of Virginia Health System reserachers have identified a key ... in the treatment of acute respiratory distress syndrome (ARDS). //The ... ,The receptor is similar to what triggers ... There is no existing treatment for ARDS in which the ...
... School of Medicine is conducting a Phase II clinical ... tumours.// ,The drug also known as bevacizumab is ... growth of blood vessels in tumours. ,The test ... with abdominal radiation therapy and chemotherapy can reduce localized ...
... WHO has warned that it is high time for ... radio frequency identification tags that would help identify fake ... that are deliberately mislabeled to cheat customers have been ... use. These medicines yield enormous profit and have remained ...
... a new antifungal drug, for the treatment of bloodstream ... // is indicated in the treatment of candidemia, a ... performance of Eraxis compared to Diflucan, a currently employed ... The drug can also be used in the treatment ...
Cached Medicine News:Health News:Avastin under trial to test efficacy for pancreatic tumours! 2Health News:Need For Smarter Ways To Identify Fake Drugs & Internet Counterfeiting: WHO 2
(Date:11/24/2014)... 2014 Juno Therapeutics today announced that ... the company,s JCAR015 chimeric antigen receptor product candidate. ... or refractory B-cell acute lymphoblastic leukemia and was ... Cancer Center, where Phase 1 clinical trials are ... is important news for patients who may benefit ...
(Date:11/24/2014)... BOCA RATON, Fla. , Nov. 24, 2014  Marta ... Aesthetic Medicine, Boca Raton , FL and international ... dermatologic physicians selected from the United States ... 14-16 in Istanbul, Turkey . Here, at ... truly meet West, as world renowned facial plastic surgery experts ...
(Date:11/24/2014)... 24, 2014  AiCure, an artificial intelligence company ... monitor medication ingestion, has announced the start of ... with patients receiving medication as maintenance therapy for ... prescription opiates have quadrupled in the last 15 ... than heroin, cocaine and benzodiazepines combined. Overall, the ...
Breaking Medicine Technology:Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3Can artificial intelligence solve the $55 billion problem of opioid abuse? 2
... new CVD Diamond Knives. New advancements in ... diamonds to be used at a more ... stromal reapproximation, enhances healing, and insures a ... uses, and are available in a variety ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
... To Safely And Easily Cut Foldable ... Designed To Cut And Remove Even ... With One Instrument.,New Miniaturized Profile Allows ... For Explantation Of A Silicone Lens.,Available ...
... As One Unit, Shaped Like A Fan, And ... A Phaco Incision. The Gauges Start At A ... To With 100-Micron Increments. The Gauges ... As To The Preoperative And Postoperative Incision Result. ...
Medicine Products: